Xie, H., Lafky, J. M., Morlan, B. W., Stella, P. J., Dakhil, S. R., Gross, G. G., . . . Grothey, A. (2020). Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: Results of the phase II North Central Cancer Treatment Group study N054C (Alliance). Ther Adv Med Oncol.
Citação norma ChicagoXie, Hao, et al. "Dual VEGF Inhibition With Sorafenib and Bevacizumab As Salvage Therapy in Metastatic Colorectal Cancer: Results of the Phase II North Central Cancer Treatment Group Study N054C (Alliance)." Ther Adv Med Oncol 2020.
MLA引文Xie, Hao, et al. "Dual VEGF Inhibition With Sorafenib and Bevacizumab As Salvage Therapy in Metastatic Colorectal Cancer: Results of the Phase II North Central Cancer Treatment Group Study N054C (Alliance)." Ther Adv Med Oncol 2020.